Physician profile
Brian B Carpenter
NPI 1154386647
$1,218,543.53
in general payments reported to CMS, 2019-2025
8 companies · $266K in 2025
The $266K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $120K · 2021: $138K · 2022: $174K · 2023: $211K · 2024: $237K · 2025: $266K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $713K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $713,138.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,173,321.40 | 2019-2025 | Arthrex |
| Osteomed LLC | $22,041.25 | 2019-2022 | |
| Acumed LLC | $13,850.27 | 2023-2024 | Osteomed |
| Arthrosurface Incorporated | $8,947.24 | 2019 | |
| Pylant Medical | $144.69 | 2019 | |
| Paragon 28, INC. | $112.14 | 2019 | |
| Organogenesis INC. | $74.49 | 2019 | |
| Medtronic Vascular, INC. | $52.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.